Oncotelic Therapeutics, Inc. (OTLC) Operating cash flow 2017–2025
Oncotelic Therapeutics, Inc. (OTLC) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$1.4MFY2025 · since FY2017: -$10.9M → -$1.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$1.4M | -86.8% |
| FY2024 | -$740,277 | +44.0% |
| FY2023 | -$1.3M | +9.1% |
| FY2022 | -$1.5M | +67.2% |
| FY2021 | -$4.4M | -57.7% |
| FY2020 | -$2.8M | -23.3% |
| FY2019 | -$2.3M | -846.4% |
| FY2018 | -$240,980 | +97.8% |
| FY2017 | -$10.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice